Diagnostics are evolving beyond their traditional role of reporting test results.
Christopher Garcia, M.D., explores how precision medicine, AI, and advanced analytics are changing what's possible in laboratory medicine.
Read the Q&A.
https://t.co/dsOE4jGCYx
Advances in genetic testing, emerging therapies, and point-of-care technologies are creating new opportunities for laboratories. See how laboratory and health system leaders are evaluating innovative diagnostics as demand grows. https://t.co/wO08YzujkW
Better decisions start with people feeling comfortable speaking up. Learn how workplace transparency can encourage diverse perspectives and honest dialogue in this microlearning. https://t.co/HoK4IRhTKH
Our neuromuscular pathology experts review more than 1,000 muscle biopsies annually. See how that unique expertise extends beyond muscle pathology for all muscle diseases. https://t.co/oWYeD2EanQ
We are transcending traditional testing for autoimmune neurological conditions. “It took a tremendous amount of discovery and translational science that happens behind the scenes," says John Mills, Ph.D., codirector of the Neuroimmunology Laboratory. https://t.co/IOJ7YTmLPN
Many patients referred with a diagnosis of autoimmune encephalitis are ultimately found to have an alternative condition. This highlights that misdiagnosis of autoimmune encephalitis is a frequent and important clinical problem. Learn more. https://t.co/pedTZrbAm8
Strategic collaboration can significantly impact diagnostics. Read our conversation with @M_J_Williamson, chief administrative officer at Mayo Clinic Laboratories, about how strategic collaborations are expanding access to advanced diagnostics. https://t.co/3N1aiRuXkh
Our precision epilepsy therapeutics supports more informed decisions and helps advance care across the epilepsy treatment journey.
Learn how this helped one patient at Mayo Clinic.
https://t.co/wev6K8DeIW
Chronic diarrhea or unexplained weight loss can have many causes. See how comprehensive malabsorption testing can help provide answers and inform disease management. https://t.co/qHND0NVEdV
Nerve biopsy testing can provide critical insights for patients experiencing certain symptoms. Learn more about when this testing is most appropriate and how Mayo Clinic Laboratories is helping with complex neuromuscular disorders.
https://t.co/ka1bMQwpM0
The Karius metagenomic sequencing test, offered in collaboration with @KariusInc, provides quick, accurate diagnosis for serious lung infections. With results typically available within one day of sample receipt, this test enables faster treatment. https://t.co/ziVtLhjFeS
Learn from the experts leading the conversation on advances in Alzheimer's disease diagnostics.
Join Mayo Clinic Laboratories and @C2NDiagnostics for our free webinar. Last chance to register.
Oct. 29
11 a.m.–noon CT
https://t.co/9MMDqORjDN
Join our free webinar on Nov. 11 to explore evidence-based interpretation strategies, common testing challenges, and practical approaches to urine drug monitoring.
Register now.
P.A.C.E.® credit is offered for this program. https://t.co/050tRR93Up
When nutrients aren’t being absorbed, the “why” matters. See how specialized testing can help identify the underlying cause of intestinal insufficiencies. https://t.co/vgPPrZv1i9
Take the next step in accessing the industry’s most accurate, clinically relevant plasma and cerebrospinal fluid biomarker evaluations for Alzheimer's disease and related dementias. Schedule an appointment with one of our team members.
https://t.co/SPLoe2qvv0
This presentation provides a glimpse into the rare disease landscape of Barbados, highlighting the challenges with limited genetic infrastructure, workforce shortages, and barriers to diagnostic testing. P.A.C.E. credit is offered for this program. https://t.co/iF3cmj8pmd
An 80-year-old with Crohn’s disease since 1990, resulting in multiple ileal resections, presented with watery diarrhea, urge incontinence, weight loss, decreased appetite, and fatigue. Learn how targeted testing guided treatment decisions. https://t.co/knfbiWzqZK
Our comprehensive oncology testing supports timely, evidence-based decisions across the full patient journey — helping you act with confidence at every stage of care.
https://t.co/Wk7QwNXXMk
For patients with myelodysplastic syndrome, a testing approach with comprehensive fluorescence in situ hybridization (FISH) panels detects genetic biomarkers associated with disease severity, progression, and treatment response. Learn more. https://t.co/DghTTJc5kc